Home/Filings/4/0001628280-22-001471
4//SEC Filing

Looker Benjamin 4

Accession 0001628280-22-001471

CIK 0001434868other

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 5:07 PM ET

Size

7.2 KB

Accession

0001628280-22-001471

Insider Transaction Report

Form 4
Period: 2022-01-27
Looker Benjamin
General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-27+100,450100,450 total
    Exercise: $3.65Exp: 2032-01-27Common Stock (100,450 underlying)
  • Award

    Common Stock

    2022-01-27+70,80070,800 total
Footnotes (2)
  • [F1]Such award will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of January 15, 2022 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service.
  • [F2]Such options will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of January 15, 2022 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service.

Issuer

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother

Related Parties

1
  • filerCIK 0001859509

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 5:07 PM ET
Size
7.2 KB